NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fiscal fourth quarter revenues rose 1 percent, driven in part by growth in its breast health and molecular diagnostics businesses.

For the three months ended Sept. 30, the firm reported revenues of $813.5 million up from $802.9 million a year ago, beating the average consensus Wall Street estimate of $806.6 million.